Copper is required for oncogenic BRAF signaling and tumorigenesis

[1]  Kate Owen,et al.  Registered Report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation , 2016, eLife.

[2]  K. Flaherty,et al.  Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.

[3]  S. Howell,et al.  Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling. , 2012, Biochemical pharmacology.

[4]  J. Utikal,et al.  Improved survival with MEK inhibition in BRAF-mutated melanoma. , 2012, The New England journal of medicine.

[5]  B. Ancrile,et al.  Targeting eNOS in pancreatic cancer. , 2012, Cancer research.

[6]  Dirk Schadendorf,et al.  Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group , 2012 .

[7]  D. Thiele,et al.  A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling , 2012, Molecular and Cellular Biology.

[8]  Kunhong Xiao,et al.  Multiple ligand-specific conformations of the β2-adrenergic receptor. , 2011, Nature chemical biology.

[9]  Ryan T. Strachan,et al.  Distinct Phosphorylation Sites on the β2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of β-Arrestin , 2011, Science Signaling.

[10]  Nikhil Wagle,et al.  Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Rosen,et al.  Resistance to BRAF inhibition in melanomas. , 2011, The New England journal of medicine.

[12]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[13]  Sin-Ho Jung,et al.  Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy , 2010, Molecular Cancer Therapeutics.

[14]  P. Zipfel,et al.  Ral activation promotes melanomagenesis , 2010, Oncogene.

[15]  C. Counter,et al.  ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis. , 2009, Carcinogenesis.

[16]  A. Krasnitz,et al.  Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. , 2009, Cancer cell.

[17]  Paul Reichert,et al.  Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors. , 2009, Biochemistry.

[18]  D. Thiele,et al.  New Roles for Copper Metabolism in Cell Proliferation, Signaling, and Disease* , 2009, Journal of Biological Chemistry.

[19]  N. Ahn,et al.  Isolation of Intrinsically Active (MEK-independent) Variants of the ERK Family of Mitogen-activated Protein (MAP) Kinases*♦ , 2008, Journal of Biological Chemistry.

[20]  F. Niesen,et al.  The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability , 2007, Nature Protocols.

[21]  Eric S. Lander,et al.  Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.

[22]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[23]  M. Serrano,et al.  A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.

[24]  K. Ashkan,et al.  Wilson's disease , 2007, The Lancet.

[25]  R. Vachet,et al.  Using metal-catalyzed oxidation reactions and mass spectrometry to identify amino acid residues within 10 Å of the metal in Cu-binding proteins , 2006, Journal of the American Society for Mass Spectrometry.

[26]  D. Thiele,et al.  Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. , 2006, Cell metabolism.

[27]  Brendan K Faherty,et al.  Optimization and Use of Peptide Mass Measurement Accuracy in Shotgun Proteomics*S , 2006, Molecular & Cellular Proteomics.

[28]  K. Hahn,et al.  PB1 Domain-Dependent Signaling Complex Is Required for Extracellular Signal-Regulated Kinase 5 Activation , 2006, Molecular and Cellular Biology.

[29]  Todd R. Golub,et al.  BRAF mutation predicts sensitivity to MEK inhibition , 2006, Nature.

[30]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[31]  R. Vachet,et al.  Metal-catalyzed oxidation reactions and mass spectrometry: the roles of ascorbate and different oxidizing agents in determining Cu-protein-binding sites. , 2005, Analytical biochemistry.

[32]  P. Khavari,et al.  Mek1 Alters Epidermal Growth and Differentiation , 2004, Cancer Research.

[33]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[34]  M. L’Abbé,et al.  Copper Modulates the Degradation of Copper Chaperone for Cu,Zn Superoxide Dismutase by the 26 S Proteosome* , 2003, Journal of Biological Chemistry.

[35]  M. Mann,et al.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.

[36]  D. Thiele,et al.  Characterization of Mouse Embryonic Cells Deficient in the Ctr1 High Affinity Copper Transporter , 2002, The Journal of Biological Chemistry.

[37]  C. Der,et al.  Distinct requirements for Ras oncogenesis in human versus mouse cells. , 2002, Genes & development.

[38]  D. Thiele,et al.  Biochemical and Genetic Analyses of Yeast and Human High Affinity Copper Transporters Suggest a Conserved Mechanism for Copper Uptake* , 2002, The Journal of Biological Chemistry.

[39]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[40]  M. White,et al.  Contribution of the ERK5/MEK5 Pathway to Ras/Raf Signaling and Growth Control* , 1999, The Journal of Biological Chemistry.

[41]  C. Der,et al.  The Mitogen-activated Protein Kinase Phosphatases PAC1, MKP-1, and MKP-2 Have Unique Substrate Specificities and Reduced Activity in Vivo toward the ERK2 sevenmaker Mutation (*) , 1996, The Journal of Biological Chemistry.

[42]  D. Kessler,et al.  Biochemical and biological analysis of Mek1 phosphorylation site mutants. , 1995, Molecular biology of the cell.

[43]  H. Nazer,et al.  Wilson's Disease. , 1991, Annals of Saudi medicine.

[44]  C. Counter,et al.  A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. , 2006, Methods in enzymology.